Conversion to Resectability Using Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma

Conversion to Resectability Using Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma

Objective:. To evaluate whether this conversion rate to resectability could be increased when patients are treated with transarterial chemoembolization and hepatic arterial infusion chemotherapy (TACE-HAIC) using oxaliplatin plus fluorouracil/leucovorin. Background:. Conventional TACE (c-TACE) is a...

Full description

Bibliographic Details
Main Authors: Binkui Li, MD, PhD, Jiliang Qiu, MD, PhD, Yun Zheng, MD, PhD, Yunxing Shi, MD, Ruhai Zou, MD, PhD, Wei He, MD, PhD, Yichuang Yuan, MD, Yuanping Zhang, MD, Chenwei Wang, MD, Zhiyu Qiu, MD, Kai Li, MD, Chengrui Zhong, MD, Yunfei Yuan, MD
Format: Article
Language:English
Published: Wolters Kluwer Health 2021-06-01
Series:Annals of Surgery Open
Online Access:http://journals.lww.com/10.1097/AS9.0000000000000057

Internet

http://journals.lww.com/10.1097/AS9.0000000000000057

Similar Items